✦ LIBER ✦

Survival of Anti-Mitochondrial Antibody-Positive and -Negative Primary Biliary Cirrhosis Patients on Ursodeoxycholic Acid Treatment

✍ Scribed by Meri Koulentaki; Joanna Moscandrea; Philipos Dimoulios; Costas Chatzicostas; Elias A. Kouroumalis

Book ID: 111578972
Publisher: Springer US
Year: 2004
Tongue: English
Weight: 122 KB
Volume: 49
Category: Article
ISSN: 0163-2116
DOI: 10.1023/b:ddas.0000037811.48575.da

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of ursodeoxycholic acid (UDCA

The effect of ursodeoxycholic acid (UDCA) on anti-mitochondrial antibody (AMA) titre in primary biliary cirrhosis (PBC)

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Effects of ursodeoxycholic acid on survi

Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis

✍ KD Lindor; TM Therneau; RA Jorgensen; M Malinchoc; ER Dickson 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Effects of ursodeoxycholic acid (UDCA) o

Effects of ursodeoxycholic acid (UDCA) on survival in patients with primary biliary cirrhosis (PBC)

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 152 KB

1305 POSITIVE ANTI-GP210 ANTIBODIES IS A

1305 POSITIVE ANTI-GP210 ANTIBODIES IS A RISK FACTOR FOR POOR BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID TREATMENT IN JAPANESE PATIENTS WITH PRIMARY BILIARY CIRRHOSIS

✍ Nakamura, M.; Ito, M.; Yamamoto, K.; Zeniya, M.; Ohira, H.; Hashimoto, E.; Honda 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Urinary excretion of ursodeoxycholic aci

Urinary excretion of ursodeoxycholic acid during treatment of patients with primary biliary cirrhosis and primary sclerosing cholangitis

📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Long-term survival and impact of ursodeo

Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation

✍ Phunchai Charatcharoenwitthaya; Sylvania Pimentel; Jayant A. Talwalkar; Felicity 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 2 views

The recurrence of primary biliary cirrhosis (PBC) in the hepatic allograft may impact patient and graft survival with long-term follow-up. The efficacy of ursodeoxycholic acid (UDCA) for treatment of recurrent PBC after liver transplantation (LT) remains less well known. The aims of this study were